510(k) K850892
K850892 is an FDA 510(k) premarket notification submitted by Immuno Nuclear Corp. for the device "SOMATOMEDIN C BY RADIOIMMUNOASSAY". The FDA issued a decision of Substantially Equivalent on June 6, 1985. The device falls under product code CFL (Radioimmunoassay, Human Growth Hormone), a Class I device regulated under 21 CFR 862.1370. Immuno Nuclear Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- June 6, 1985
- Date Received
- March 4, 1985
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioimmunoassay, Human Growth Hormone
- Device Class
- Class I
- Regulation Number
- 862.1370
- Review Panel
- CH
- Submission Type